Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02134015 |
| Title | Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung) |
| Acronym | HER3-Lung |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Daiichi Sankyo Inc., Parexel |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | POL | ITA | HUN | GBR | ESP | DEU | CZE | CAN | BEL |